Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Lower Cost The affordability factor cannot be overstated
Their AI doctor uses the latest medical research to guide you safely
In a Phase 2b/c trial, a four-month quabodepistat regimen combined with delamanid and bedaquiline achieved safety and efficacy broadly similar to the standard six-month four-drug regimen in drug-susceptible TB, although exploratory follow-up suggested that a more potent fourth drug may be needed to reliably shorten treatment
Retrospective observational study on riboflavin prophylaxis in child and adolescent migraine
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
